Friday, April 24, 2020

April 24, 2020 at 07:24PM Safety Reporting Requirements for INDs (Investigational New Drug Applications) and BA/BE (Bioavailability/Bioequivalence) Studies

Guidance for Industry and Investigators - Safety Reporting Requirements for INDs (Investigational New Drug Applications) and BA/BE (Bioavailability/Bioequivalence) Studies, Drug Safety

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2KuatRR

No comments:

Post a Comment